About Sanguina
Sanguina is a company based in Atlanta (United States) founded in 2014. Sanguina has raised $2.8 million across 5 funding rounds from investors including HHS, Stephen Ippolito and George Hornig. Sanguina offers products and services including AnemoCheck Home, AnemoCheck Mobile, and Ruby Premium. Sanguina operates in a competitive market with competitors including Biomaneo, Blaze Medical Devices, DiaSpect, Aviv Biomedical and MicroDevice Engineering, among others.
- Headquarter Atlanta, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sanguina, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.8 M (USD)
in 5 rounds
-
Latest Funding Round
$2.8 M (USD), Series A
Jul 25, 2023
-
Investors
HHS
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sanguina
Sanguina offers a comprehensive portfolio of products and services, including AnemoCheck Home, AnemoCheck Mobile, and Ruby Premium.
Kit for affordable anemia detection at home.
App for tracking and managing blood health.
Premium features for unlimited tests and personalized insights.
People of Sanguina
Unlock access to complete
Unlock access to complete
Funding Insights of Sanguina
Sanguina has successfully raised a total of $2.8M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $2.8 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sanguina
Sanguina has secured backing from 5 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include HHS, Stephen Ippolito and George Hornig.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Veritus is engaged in socially responsible and sustainable investing.
|
Locked | Locked | Locked | |
|
Early-stage entrepreneur-led investing is facilitated by The Seed Lab.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Sanguina
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sanguina
Investment portfolio details for Sanguina
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sanguina
Detailed financials for Sanguina
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sanguina Comparisons
Peer comparison for Sanguina
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sanguina
Sanguina operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biomaneo, Blaze Medical Devices, DiaSpect, Aviv Biomedical and MicroDevice Engineering, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neonatal screening kits for sickle cell disease are developed.
|
|
| Locked | Locked | Locked |
Testing of blood damage and health of RBC
|
|
| Locked | Locked | Locked |
Handheld hemoglobin analyzers for reagent-free whole blood testing are developed.
|
|
| Locked | Locked | Locked |
Aviv Biomedical offers a portfolio of spectrometers and fluorometers.
|
|
| Locked | Locked | Locked |
Develops point-of-care devices for effective anemia screening in healthcare settings.
|
Detailed competitors of Sanguina
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sanguina
Complete news archive for Sanguina
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanguina
Sanguina was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Sanguina is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Sanguina is a funded company, having raised a total of $2.8M across 5 funding rounds to date.
Founded in 2014 and based in Atlanta, United States, operations are focused on health diagnostics. A disposable point-of-care testing device is developed and marketed for anemia detection. Analysis of one blood droplet is performed via a chemical reagent that generates color changes indicating hemoglobin levels. Results are obtained in approximately 60 seconds without electrical power requirements. Integration with smartphones is supported for automated correlation to specific hemoglobin measurements.
Sanguina's top competitors include Biomaneo, DiaSpect and Blaze Medical Devices.
Sanguina offers AnemoCheck Home, AnemoCheck Mobile, and Ruby Premium.
Sanguina has 5 investors. Key investors include HHS, Stephen Ippolito, George Hornig, Veritus, and The Seed Lab.